Personal information

Other IDs

Loop profile: 587960
Scopus Author ID: 56228022100

Keywords

Transglutaminases; Neurodegenerative diseases

Countries

Italy

Biography

PERSONAL DATA:

DATE AND PLACE OF BIRTH :
July 06, 1960; Torre del Greco, Naples, Italy.

CITIZENSHIP:
Italian.

LANGUAGES:
Italian, English, French.

Activities

Collapse all

Employment (4)

University of Texas Medical School at Houston: Houston, TX, US

1992-11-01 to 1993-11-01 | Visiting professor (Department of Pharmacology)
Employment
Source: Self-asserted source
Vittorio Gentile

FIDIA SpA: Abano Terme, Veneto, IT

1991-07-01 to 1992-07-01 | Scientific consultant
Employment
Source: Self-asserted source
Vittorio Gentile

University of Texas Medical School at Houston: Houston, TX, US

1988-11-01 to 1991-07-01 | Fellow (Department of Pharmacology)
Employment
Source: Self-asserted source
Vittorio Gentile

Laboratorio di Tossicologia Comparata ed Ecotossicologia: Rome, Italy, IT

1986-10-01 to 1987-10-01 | Fellow (Istituto Superiore di Sanità)
Employment
Source: Self-asserted source
Vittorio Gentile

Education and qualifications (3)

University of Naples: Naples, Italy, IT

1984-11-01 to 1991-07-29 | Specialist in Neurology
Education
Source: Self-asserted source
Vittorio Gentile

University of Naples: Naples, Italy, IT

1986-11-01 to 1990-07-30 | Ph.D. in Biochemical Sciences
Education
Source: Self-asserted source
Vittorio Gentile

1st Medical School, University of Naples : Naples, Italy, IT

1978-11-01 to 1984-07-31 | M.D. (Biochemistry and Biophysics)
Education
Source: Self-asserted source
Vittorio Gentile

Funding (4)

Identification and characterization of transglutaminase genes in the Nervous System in relationship to the development of neurodegenerative diseases.

2014-01 to present | Grant
Regione Campania (Naples, IT)
Source: Self-asserted source
Vittorio Gentile

A biochemical mechanism for CAG triplet diseases: a glutamine expansion that can produce new substrates for transglutaminase activity in degenerating neuronal cells.

1998-01 to 2000-01 | Grant
Fondazione Telethon (Naples, IT)
GRANT_NUMBER:

E.0719
Source: Self-asserted source
Vittorio Gentile

A biochemical mechanism for CAG triplet diseases: a glutamine expansion that can produce new substrates for transglutaminase activity in degenerating neuronal cells?

1995-01 to 1997-01 | Grant
Fondazione Telethon (Naples, IT)
GRANT_NUMBER:

E.217
Source: Self-asserted source
Vittorio Gentile

Possible role of the endothelial cell transglutaminase as mediator of cancer cell adhesivity.

1995 to 1997 | Grant
AIRC (Naples, IT)
Source: Self-asserted source
Vittorio Gentile

Works (50 of 56)

Items per page:
Page 1 of 2

Immune cell infiltration and inflammatory landscape in primary brain tumours

Journal of Translational Medicine
2024 | Journal article
DOI: 10.1186/s12967-024-05309-1
EID:

2-s2.0-85195009051

Part of ISSN: 14795876
Contributors: Luce, A.; Abate, M.; Scognamiglio, G.; Montella, M.; Iervolino, D.; Campione, S.; Di Mauro, A.; Sepe, O.; Gigantino, V.; Tathode, M.S. et al.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Amyloid-β-Induced Transglutaminase 2 Expression and Activities are Modulated by 2-Pentadecyl-2-Oxazoline in Mouse and Human Microglial Cell Lines

Current Alzheimer Research
2023 | Journal article
DOI: 10.2174/1567205020666230804100831
EID:

2-s2.0-85172759589

Part of ISSN: 18755828 15672050
Contributors: Parente, A.; Giacca, R.; Arena, R.; Rullo, I.; Guida, F.; Maione, S.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play

Biomedicine and Pharmacotherapy
2022 | Journal article
DOI: 10.1016/j.biopha.2022.113844
EID:

2-s2.0-85142403141

Part of ISSN: 19506007 07533322
Contributors: Infantino, R.; Boccella, S.; Scuteri, D.; Perrone, M.; Ricciardi, F.; Vitale, R.M.; Bonsale, R.; Parente, A.; Allocca, I.; Virtuoso, A. et al.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Neuronutraceuticals modulate lipopolysaccharide-or amyloid-β 1-42 peptide-induced transglutaminase 2 overexpression as a marker of neuroinflammation in mouse microglial cells

Applied Sciences (Switzerland)
2021 | Journal article
DOI: 10.3390/app11125718
EID:

2-s2.0-85109036589

Part of ISSN: 20763417
Contributors: Gatta, N.G.; Parente, A.; Guida, F.; Maione, S.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier
grade
Preferred source (of 3)‎

Curcumin (diferulolylmethane) reduces transglutaminase 2 overexpression induced by retinoic acid in human nervous cell lines

NeuroImmunoModulation
2016 | Journal article
DOI: 10.1159/000448998
EID:

2-s2.0-84992712515

Part of ISBN:

14230216 10217401
Contributors: Gatta, N.G.; Cammarota, G.; Iannaccone, M.; Serretiello, E.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases

Biophysics (Russian Federation)
2016 | Journal article
DOI: 10.3934/biophy.2016.4.529
EID:

2-s2.0-84996761534

Part of ISBN:

15556654 00063509
Contributors: Gatta, N.G.; Cammarota, G.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Meet our editorial board member

Recent Patents on CNS Drug Discovery
2015 | Journal article
EID:

2-s2.0-84938695156
Contributors: Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible pathophysiological roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases

AIMS Biophysics
2015 | Journal article
DOI: 10.3934/biophy.2015.4.441
EID:

2-s2.0-85018658926

Part of ISBN:

23779098
Contributors: Serretiello, E.; Iannaccone, M.; Titta, F.; Gatta, N.G.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible rol of reactions catalyzed by transglutaminases in the pathogenesis of neurodegenerative diseases | Posible papel de las reacciones catalizadas por transglutaminasa en la patogénesis de enfermedades neurodegenerativas

Prensa Medica Argentina
2015 | Journal article
EID:

2-s2.0-84953213633
Contributors: Lannaccone, M.; Titta, F.; Serretiello, E.; Marra, F.; Martin, A.; De Vivo, G.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible role of transglutaminase catalyzed reactions in the pathogenesis of neurodegenerative diseases,Posible papel de las reacciones catalizadas por transglutaminasa en la patogénesis de enfermedades neurodegenerativas

Prensa Medica Argentina
2015 | Journal article
EID:

2-s2.0-85073162195

Part of ISBN:

0032745X
Contributors: Iannaccone, M.; Titta, F.; Serretiello, E.; Marra, F.; Martin, A.; De Vivo, G.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases

Recent Patents on CNS Drug Discovery
2014 | Journal article
EID:

2-s2.0-84919709241
Contributors: Iannaccone, M.; Titta, F.; Serretiello, E.; Monfregola, M.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases

Recent Patents on CNS Drug Discovery
2014 | Journal article
EID:

2-s2.0-84919721780
Contributors: Titta, F.; Iannaccone, M.; Martin, A.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Original article identification of a FXIIIA variant in human neuroblastoma cell lines

International Journal of Biochemistry and Molecular Biology
2013 | Journal article
EID:

2-s2.0-84881497200
Contributors: Lannaccone, M.; Giuberti, G.; De Vivo, G.; Caraglia, M.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases

Amino Acids
2013 | Journal article
DOI: 10.1007/s00726-011-1081-1
EID:

2-s2.0-84871960070
Contributors: Martin, A.; Giuliano, A.; Collaro, D.; De Vivo, G.; Sedia, C.; Serretiello, E.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminase activity as a possible therapeutical target in neurode-generative diseases

Recent Patents on CNS Drug Discovery
2013 | Journal article
DOI: 10.2174/1574889808666131128105630
EID:

2-s2.0-84892551896
Contributors: Iannaccone, M.; Titta, F.; Serretiello, E.; De Vivo, G.; Martin, A.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.

Recent patents on CNS drug discovery
2013 | Journal article
EID:

2-s2.0-84907169092
Contributors: Iannaccone, M.; Serretiello, E.; De Vivo, G.; Martin, A.; Stefanile, A.; Titta, F.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human diseases

Inflammation and Allergy - Drug Targets
2012 | Journal article
DOI: 10.2174/187152812800959004
EID:

2-s2.0-84869859115
Contributors: Martin, A.; de Vivo, G.; Iannaccone, M.; Stefanile, A.; Serretiello, E.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Physiopathological roles of human transglutaminase 2

Advances in Enzymology and Related Areas of Molecular Biology
2011 | Book
EID:

2-s2.0-84856623809
Contributors: Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Possible role of the transglutaminases in the pathogenesis of alzheimer's disease and other neurodegenerative diseases

International Journal of Alzheimer's Disease
2011 | Journal article
DOI: 10.4061/2011/865432
EID:

2-s2.0-79953286790
Contributors: Martin, A.; Gentile, V.; De Vivo, G.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier
grade
Preferred source (of 2)‎

Transglutaminases as possible therapeutic targets in neurodegenerative diseases

Recent Patents on CNS Drug Discovery
2010 | Journal article
DOI: 10.2174/157488910793362430
EID:

2-s2.0-78649375466
Contributors: Martin, A.; de Vivo, G.D.; Ricotta, M.; Iannuzzi, M.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases

Current Medicinal Chemistry
2009 | Journal article
DOI: 10.2174/092986709789909594
EID:

2-s2.0-71949104177
Contributors: De Vivo, G.; Di Lorenzo, R.; Ricotta, M.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders

Inflammation and Allergy - Drug Targets
2008 | Journal article
DOI: 10.2174/187152808784165171
EID:

2-s2.0-43449139432
Contributors: de vivo, G.; Martin, A.; Trotta, T.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases

CNS and Neurological Disorders - Drug Targets
2008 | Journal article
DOI: 10.2174/187152708786441821
EID:

2-s2.0-60549085648
Contributors: De Vivo, G.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac disease

Frontiers in Bioscience
2006 | Journal article
DOI: 10.2741/1795
EID:

2-s2.0-32844470135
Contributors: Amantea, G.; Cammarano, M.; Zefferino, L.; Martin, A.; Romito, G.; Piccirillo, M.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: From basic biochemistry to clinic

Current Medicinal Chemistry
2006 | Journal article
DOI: 10.2174/092986706777585068
EID:

2-s2.0-33745755214
Contributors: Martin, A.; Romito, G.; Pepe, I.; De Vivo, G.; Merola, M.R.; Limatola, A.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: Minireview article

Amino Acids
2004 | Conference paper
DOI: 10.1007/s00726-004-0089-1
EID:

2-s2.0-4143057989

Part of ISSN: 09394451
Contributors: Pepe, I.; Occhino, E.; Cella, G.; Luongo, A.; Guardascione, F.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminases - Possible drug targets in human diseases

Current Drug Targets: CNS and Neurological Disorders
2004 | Journal article
DOI: 10.2174/1568007043482552
EID:

2-s2.0-2642542496
Contributors: Gentile, V.; Cooper, A.J.L.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Abnormal accumulation of tTgase products in muscle and erythrocytes of chorea-acanthocytosis patients

Journal of Neuropathology and Experimental Neurology
2002 | Journal article
EID:

2-s2.0-0036792882
Contributors: Melone, M.A.B.; Di Fede, G.; Peluso, G.; Lus, G.; Di Iorio, G.; Sampaolo, S.; Capasso, A.; Gentile, V.; Cotrufo, R.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: Does transglutaminase activity play a role in (CAG)<sub>n</sub>/Q<sub>n</sub>-expansion diseases?

Neurochemistry International
2002 | Conference paper
DOI: 10.1016/S0197-0186(01)00058-4
EID:

2-s2.0-0036134811

Part of ISSN: 01970186
Contributors: Cooper, A.J.L.; Jeitner, T.M.; Gentile, V.; Blass, J.P.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier
grade
Preferred source (of 2)‎

Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases

Neurochemistry International
2002-01 | Journal article
DOI: 10.1016/s0197-0186(01)00063-8
Contributors: Vittorio Gentile; Vittorio Violante; Bonifacio D'Amico; Michele Illiano; Antonio Luongo
Source: Self-asserted source
Vittorio Gentile via Crossref Metadata Search
grade
Preferred source (of 2)‎

Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases

Brain Research Bulletin
2001 | Conference paper
DOI: 10.1016/S0361-9230(01)00576-7
EID:

2-s2.0-0035503865

Part of ISSN: 03619230
Contributors: Violante, V.; Luongo, A.; Pepe, I.; Annunziata, S.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells

Journal of Clinical Endocrinology and Metabolism
1999 | Journal article
EID:

2-s2.0-0033342825
Contributors: Pasquali, D.; Rossi, V.; Prezioso, D.; Gentile, V.; Colantuoni, V.; Lotti, T.; Bellastella, A.; Sinisi, A.A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Pathogenesis of inclusion bodies in (CAG)(n)/Q(n)-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability

Journal of Neurochemistry
1999 | Journal article
DOI: 10.1046/j.1471-4159.1999.0720889.x
EID:

2-s2.0-0033012131
Contributors: Cooper, A.J.L.; Sheu, K.-F.R.; Burke, J.R.; Strittmatter, W.J.; Gentile, V.; Peluso, G.; Blass, J.P.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Tissue transglutaminase expression in quail epiphyseal chondrocytes

Cell Biology International
1999 | Journal article
DOI: 10.1006/cbir.1998.0316
EID:

2-s2.0-0032752129
Contributors: Sanchez, M.; Arcella, A.; Pontarelli, G.; Tavassi, S.; Gentile, V.; Cozzolino, A.; Porta, R.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells

FEBS Letters
1998 | Journal article
DOI: 10.1016/S0014-5793(98)01191-0
EID:

2-s2.0-0032538613
Contributors: Beninati, S.; Gentile, V.; Caraglia, M.; Lentini, A.; Tagliaferri, P.; Abbruzzese, A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: A possible mechanism contributing to CAG-triplet diseases

Archives of Biochemistry and Biophysics
1998 | Journal article
DOI: 10.1006/abbi.1998.0592
EID:

2-s2.0-0032522165
Contributors: Gentile, V.; Sepe, C.; Calvani, M.; Melone, M.A.B.; Cotrufo, R.; Cooper, A.J.L.; Blass, J.P.; Peluso, G.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: Relationship to development of autoimmunity in MRLlpr/lpr mice

Cell Death and Differentiation
1997 | Journal article
EID:

2-s2.0-14044258854
Contributors: Piredda, L.; Amendola, A.; Colizzi, V.; Davies, P.J.A.; Farrace, M.G.; Fraziano, M.; Gentile, V.; Uray, I.; Piacentini, M.; Fesus, L.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

tTGase/Gαh protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranes

Biochimica et Biophysica Acta - Molecular Cell Research
1997 | Journal article
DOI: 10.1016/S0167-4889(97)00024-4
EID:

2-s2.0-0030982708
Contributors: Gentile, V.; Porta, R.; Chiosi, E.; Spina, A.; Valente, F.; Pezone, R.; Davies, P.J.A.; Alaadik, A.; Illiano, G.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Cell-biomaterial interactions: Role of transglutaminase enzyme

Journal of Materials Science: Materials in Medicine
1996 | Journal article
EID:

2-s2.0-0030561525
Contributors: Peluso, G.; Petillo, O.; Mazzarella, L.; La Cara, F.; Sada, A.; Melone, M.A.B.; Davies, P.J.A.; Gentile, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Isolation and characterization of the human tissue transglutaminase gene promoter

Journal of Biological Chemistry
1995 | Journal article
DOI: 10.1074/jbc.270.17.9748
EID:

2-s2.0-0028907482
Contributors: Lu, S.; Saydak, M.; Gentile, V.; Stein, J.P.; Davies, P.J.A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Localization of the human prostate transglutaminase (type iv) gene (tgm4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization

Genomics
1995 | Journal article
DOI: 10.1006/geno.1995.1032
EID:

2-s2.0-0029001467
Contributors: Gentile, V.; Grant, F.J.; Porta, R.; Baldini, A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression

FEBS Letters
1995 | Journal article
DOI: 10.1016/0014-5793(95)00782-5
EID:

2-s2.0-0029088221
Contributors: Mian, S.; El Alaoui, S.; Lawry, J.; Gentile, V.; Davies, P.J.A.; Griffin, M.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization

Genomics
1994 | Journal article
DOI: 10.1006/geno.1994.1170
EID:

2-s2.0-0028220758
Contributors: Gentile, V.; Davies, P.J.A.; Baldini, A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells

Molecular and Cellular Biology
1994 | Journal article
EID:

2-s2.0-0028060558
Contributors: Melino, G.; Annicchiarico-Petruzzelli, M.; Piredda, L.; Candi, E.; Gentile, V.; Davies, P.J.A.; Piacentini, M.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth

Oncogene
1994 | Journal article
EID:

2-s2.0-0028129461
Contributors: Johnson, T.S.; Knight, C.R.L.; El-Alaoui, S.; Mian, S.; Rees, R.C.; Gentile, V.; Davies, P.J.A.; Griffin, M.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein GP120 in vitro

International Journal of Peptide and Protein Research
1993 | Journal article
EID:

2-s2.0-0027171106
Contributors: Mariniello, L.; Esposito, C.; Gentile, V.; Porta, R.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: Effects on cellular morphology and adhesion

Journal of Cell Biology
1992 | Journal article
EID:

2-s2.0-0026705663
Contributors: Gentile, V.; Thomazy, V.; Piacentini, M.; Fesus, L.; Davies, P.J.A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases

Journal of Biological Chemistry
1991 | Journal article
EID:

2-s2.0-0026018479
Contributors: Gentile, V.; Saydak, M.; Chiocca, E.A.; Akande, O.; Birckbichler, P.J.; Lee, K.N.; Stein, J.P.; Davies, P.J.A.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides

Gastroenterology
1990 | Journal article
EID:

2-s2.0-0025204536
Contributors: Auricchio, S.; de Ritis, G.; de Vincenzi, M.; Gentile, V.; Maiuri, L.; Mancini, E.; Porta, R.; Raia, V.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier

Cereal dietary proteins with sites for cross-linking by transglutaminase

Phytochemistry
1990 | Journal article
DOI: 10.1016/0031-9422(90)87079-A
EID:

2-s2.0-0001602639
Contributors: Porta, R.; Gentile, V.; Esposito, C.; Mariniello, L.; Auricchio, S.
Source: Self-asserted source
Vittorio Gentile via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (1 review for 1 publication/grant)

Review activity for International journal of molecular sciences. (1)
How many people are using ORCID?